Expression of B-myb in neuroblastoma tumors is a poor prognostic factor independent from MYCN amplification

Cancer Research

Volumn 59, Issue 14, 1999, Pages 3365-3368

  Raschellà, Giuseppe ^a,e   Cesi, Vincenzo ^a   Amendola, Roberto ^a   Negroni, Anna ^a   Tanno, Barbara ^a   Altavista, Pierluigi ^a   Tonini, Gian Paolo ^b   De Bernardi, Bruno ^c   Calabretta, Bruno ^d,e  

^a ENEA C R CASACCIA   (Italy)

^b ADVANCED BIOTECHNOLOGY CENTER   (Italy)

^c G GASLINI INSTITUTE   (Italy)

^d THOMAS JEFFERSON UNIVERSITY   (United States)

^e THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CANCER STAGING; CANCER SURVIVAL; CHILD; DISEASE ASSOCIATION; GENE AMPLIFICATION; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; INFANT; MAJOR CLINICAL STUDY; NEUROBLASTOMA; PRIORITY JOURNAL; PROGNOSIS; RISK;

CELL CYCLE PROTEINS; CHILD; CHILD, PRESCHOOL; DNA-BINDING PROTEINS; FOLLOW-UP STUDIES; GENE AMPLIFICATION; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, MYC; HUMANS; INFANT; INFANT, NEWBORN; NEUROBLASTOMA; ONCOGENES; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; RNA, NEOPLASM; SURVIVAL ANALYSIS; TRANS-ACTIVATORS;

EID: 0033565239     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Tsokos, M., Scarpa, S., Ross, R. A., and Triche, T. J. Differentiation of human neuroblastoma recapitulates neural crest development. Study of morphology, neurotransmitter enzymes and extracellular-matrix proteins. Am. J. Pathol., 128: 484-496, 1986.
2. Everson, T. C. Spontaneous regression of cancer. Ann. NY Acad. Sci., 114: 721-735, 1964.
3. Evans, A. E., D'Angiò, G. J., Propert, K., Anderson, J., and Hann, H. L. Prognostic factors in neuroblastoma. Cancer (Phila.), 59: 1853-1859, 1987.
4. Brodeur, G. M., Pritchard, J., Berthold, F., Carlsen, N. L., Castel, V., Castleberry, R. P., De Bernardi, B., Evans, A. E., Favrot, M., Hedborg, F., Kaneko, M., Kemshead, J., Lampert, F., Lee, R. E. J., Look, T., Pearson, A. D. J., Philip, T., Roald, B., Sawada, T., Seeger, R. C., Tsuchida, Y., and Voute, P. A. Revisions of the international criteria for neuroblastoma diagnosis, staging, and response to treatment. J. Clin. Oncol., 11: 1466-1477, 1993.
5. Silber, J. H., Evans, A. E., and Fridman, M. Models to predict outcome from childhood neuroblastoma: the role of serum ferritin and tumor histology. Cancer Res., 51: 1426-1433, 1991.
6. Shuster, J. J., McWilliams, N. B., Castleberry, R., Nischke, R., Smith, E. I., Altshuler, G., Kun, L., Brodeur, G., Joshi, V., and Vietti, T. Serum lactate dehydrogenase in childhood neuroblastoma. Am. J. Clin. Oncol., 15: 295-303, 1992.
7. Seeger, R. C., Brodeur, G. M., Sather, H., Dalton, A., Siegel, S. E., Wong, K. Y., and Hammond, D. Association of multiple copies of the N-myc oncogene with rapid progression of neuroblastoma. N. Engl. J. Med., 313: 1111-1116, 1985.
8. Maris, J. M., White, P. S., Beltinger, C. P., Sulman, E. P., Castleberry, R. P., Shuster, J. J., Look, A. T., and Brodeur, G. M. Significance of chromosome Ip loss of heterozygosity in neuroblastoma. Cancer Res., 55: 4664-4669, 1995.
9. Kogner, P., Barbany, G., Dominici, C., Castello, M. A., Raschellà, G., and Persson, H. Co-expression of mRNA for TRK protooncogene and low affinity nerve growth factor receptor in neuroblastoma with favorable prognosis. Cancer Res., 53: 2044-2050, 1993.
10. Gehring, M., Berthold, F., Edler, L., Schwab, M., and Amler, L. C. The 1p deletion is not a reliable marker for the prognosis of patients with neuroblastoma. Cancer Res., 55: 5366-5369, 1995.
11. Berthold, F., Sahin, K., Hero, B., Christiansen, H., Gerhing, M., Harms, D., Horz, S., Lampert, F., Schwab, M., and Terpe, J. The current contribution of molecular factors to risk estimation in neuroblastoma patients. Eur. J. Cancer, 33: 2092-2097, 1997.
12. Weston, K. Myb proteins in life, death and differentiation. Curr. Opin. Genet. Dev., 8: 76-81, 1998.
13. Saville, M. K., and Watson, R. J. B-myb: a key regulator of the cell cycle. Adv. Cancer Res., 72: 100-140, 1998.
14. Raschellà, G., Tanno, B., Bonetto, F., Amendola, R., Battista, T., DeLuca, A., Giordano, A., and Paggi, M. G. Retinoblastoma-related protein pRb2/130 and its binding to the B-myb promoter increase during human neuroblastoma differentiation. J. Cell. Biochem., 67: 297-303, 1997.
15. Thiele, C. J., Cohen, P. S., and Israel, M. A. Regulation of c-myb expression in human neuroblastoma cells during retinoic acid-induced differentiation. Mol. Cell. Biol., 8: 1677-1683, 1988.
16. Calabretta, B., Sims, R. B., Valtieri, M., Caracciolo, D., Szczylik, C., Venturelli, D., Beran, M., and Gewirtz, A. M. Normal and leukemic hematopoietic cells manifest differential sensitivity to inhibitory effects of c-myb antisense oligodeoxynucleotides: an in vitro study with relevance to bone marrow purging. Proc. Natl. Acad. Sci. USA, 88: 2351-2355, 1991.
17. Raschellà, G., Negroni, A., Skorski, T., Pucci, S., Nieborowska-Skorska, M., Romeo, A., and Calabretta, B. Inhibition of proliferation by c-myb anlisense RNA and oligodeoxynucleotides in transformed neuroectodermal cell lines. Cancer Res., 52: 4221-4226, 1992.
18. Piacentini, M., Raschellà, G., Calabretta, B., and Melino, G. c-myb downregulation is associated with apoptosis in human neuroblastoma cells. Cell Death Differ., 1: 85-92, 1994.
19. Raschellà, G., Negroni, A., Sala, A, Pucci, S., Romeo, A., and Calabretta, B. Requirement of B-myb function for survival and differentiative potential of human neuroblastoma cells. J. Biol. Chem., 270: 8540-8545, 1995.
20. Nomura, N., Takahashi, M., Matsui, M., Ishii, S., Date, T., Sasamoto, S., and Ishizaki, R. Isolation of human cDNA clones of myb-related genes A-myb and B-myb. Nucleic Acids Res., 16: 11075-11089, 1988.
21. Chomczynski, P., and Sacchi, N. Single step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem., 162: 156-159, 1987.
22. Cox, D. R. Regression models and life tables. J. R. Statistics Soc., 334: 187-220, 1972.
23. Kaplan, E. L., and Meier, P. Nonparametric estimation from incomplete observations. J. Am. Stat. Assoc., 53: 457-481, 1958.
24. Kaneko, M., Nishihira, H., Mugishima, H., Oharuma, N., Nakada, K., Kawa, K., Fukuzawa, M., Suita, S., Sera, Y., and Tsuchida, Y. Stratification of treatment of stage 4 neuroblastoma patients based on N-myb amplification status. Study group of Japan for treatment of advanced neuroblastoma. Med. Pediatr. Oncol., 31: 1-7, 1998.
25. Bies, J., Hoffman, B., Amanullah, A., Giese, T., and Wolff, L. B-myb prevents growth arrest associated with terminal differentiation of monocytic cells. Oncogene, 12: 355-363, 1996.
26. Sala, A., and Calabretta, B. Regulation of BALB/c3T3 fibroblast proliferation by B-myb is accompanied by selective activation of cdc2 and cyclin D1 expression. Proc. Natl. Acad. Sci. USA, 89: 10415-10419, 1992.
27. Sala, A., Casella, I., Bellon, T., Calabretta, B., Watson, R. J., and Peschle, C. B-myb promotes S phase and is a downstream target of the negative regulator p107 in human cells. J. Biol. Chem., 271: 9363-9367, 1996.
28. Hibi, K., Liu, Q., Beaudry, G. A., Madden, S. L., Westra, W. H., Wehage, S. L., Yang, S. C., Heitmiller, R. F., Bertelsen, A. H., Sidransky, D., and Jen, J. Serial analysis of gene expression in non-small cell lung cancer. Cancer Res., 58: 5690-5694, 1998.
29. Raschellà, G., Negroni, A., Pucci, S., Amendola, R., Valeri, S., and Calabretta, B. B-myb transcriptional regulation and mRNA stability during differentiation of neuroblastoma cells. Exp. Cell. Res., 222: 395-399, 1996.
30. Frampton, J., Ramquist, T., and Graf, T. v-Myb of E26 leukemia virus upregulates bcl-2 and suppresses apoptosis in myeloid cells. Genes Dev., 10: 2720-2731, 1996.
31. Taylor, D., Badiani, P., and Weston, K. A dominant interfering Myb mutant causes apoptosis in T cells. Genes Dev., 10: 2732-2744, 1996.
32. Salomoni, P., Perrotti, D., Martinez, R., Franceschi, C., and Calabretta, B. Resistance to apoptosis in CTL-2 cells constitutively expressing c-myb is associated with induction of BCL-2 expression and myb-dependent regulation of bcl-2 promoter activity. Proc. Natl. Acad. Sci. USA, 94: 3296-3301, 1997.